Solara Active Pharma Sciences Ltd
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|
| Revenue | 392.57 | 349 | 314.03 |
| Operating Expense | 329.74 | 318.40 | 278.79 |
| Net Profit | 9.73 | -17.42 | -10.08 |
| Net Profit Margin | 2.48% | -4.99% | -3.21% |
| Earning Per Share | 2.23 | -3.97 | -2.36 |
| EBIDTA | 62.83 | 30.60 | 35.24 |
| Effective Tax Rate | 0% | 0% | 0% |
Particulars
Mar 2026
Revenue392.57
Operating Expense329.74
Net Profit9.73
Net Profit Margin2.48
Earning Per Share2.23
EBIDTA62.83
Effective Tax Rate0
